pralsetinib 100 MG Oral Capsule [Gavreto]

RxNorm concept 2394947, branded drug (sbd). Prescribable name: GAVRETO 100 MG Oral Capsule.

RxCUI: 2394947
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2394947 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

pralsetinib 2394936

Other names

Gavreto 100 MG Oral Capsule

Related concepts

pralsetinib 100 MG (SCDC, consists of)
pralsetinib 100 MG [Gavreto] (SBDC, consists of)
Oral Capsule (DF, has dose form)
Gavreto (BN, has ingredient)
pralsetinib 100 MG Oral Capsule (SCD, tradename of)

Linked data

NDCs

50242021012
50242021060
50242021083
50242021090
71332000612
71332000660
71332000690
72064021060
72064021090

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2394947 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2394947 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2394947. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.